The use of hydroxychloroquine as a treatment for COVID-19 serves as an example of what is wrong with medical information being widely disseminated before it is thoroughly vetted by peer review. Preliminary studies of this treatment modality were spread widely, creating false hope that a treatment for COVID-19 existed. Several randomized trials have shown that hydroxychloroquine is not an effective therapy for COVID-19.
David Juurlink, MD, PhD, from the University of Toronto summarizes the evidence base regarding hydroxychloroquine and COVID-19.
Related Article(s):
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
Treatments to Decrease Severe Respiratory Syncytial Virus (RSV) Illness
Chronic Pruritus
The Federal Trade Commission’s Role in the Oversight of Drug Companies
Financial Incentives for Weight Loss in Men With Obesity
Service Animals in Health Care Settings
USPSTF Recommendation: Screening for Breast Cancer
Diagnosis and Treatment of Interstitial Lung Disease
Clinical Diagnosis of Dislocated Hips in Newborns
Diagnosis and Treatment of Systemic Lupus Erythematosus
Falls in Community-Dwelling Older Adults
Diagnoses and Treatment of Common Oral Conditions
USPSTF Recommendation: Primary Care Interventions to Prevent Child Maltreatment
Arteriovenous Access for Hemodialysis
Diagnosis and Treatment of Allergic Rhinitis
Heart Failure Due to Transthyretin Protein Amyloidosis
Long-Term Outcomes After Bariatric Surgery for Type 2 Diabetes
Diagnosis and Management of Paroxysmal Supraventricular Tachycardia
Prevention and Treatment of Severe Food Allergies
Climate Change and Health: A New JAMA Series
Thyroid Cancer
Create your
podcast in
minutes
It is Free
Good Mood Revolution
JAMA Editors’ Summary
JAMA Medical News
JAMAevidence The Rational Clinical Examination
JAMA Psychiatry Author Interviews
JAMA Internal Medicine Author Interviews